All News
Excited to share our recent work "IPAF: What the Rheumatologist Needs to Know."
@jeffsparks @UnaMakris @DrDavidKarp @UTSW_LungLadies @UTSWRheum https://t.co/O0BsrRyHx8 https://t.co/R3lQMGFgUb
Elena Joerns EJoerns ( View Tweet)
🔥Hot off the press🔥
🆕Our Comments on various GC protocols in @IJRheum
The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
https://t.co/4BjfkvPVAY https://t.co/gMXg7qQJWY
Kunal Chandwar kunalchandwar ( View Tweet)
do we need another IL17a inhibitor? https://t.co/yf8cFNruzU
Peter Nash drpnash ( View Tweet)
"Implementation (of guidelines) is key but remains the weakest part of the process" Dr. @DanielAletaha #EULAR2022 @RheumNow https://t.co/9ULIAA7dvg
Dr. Rachel Tate uptoTate ( View Tweet)
Easy clinical tool for predicting lymphoma development at the time of #Sjogrens syndrome #EULAR2022 https://t.co/tQ6B0iVRnb
Christian Ammitzbøll RheumTweeter ( View Tweet)
Dr Buch. ORAL Surveillance. MACE, VTE, Malignancy all more common in those with high (>20%) baseline CV risk or history CAD. HRs 1-2 for most but for VTE and high baseline CV risk, HR 6-11! @RheumNow #EULAR2022 POS0237 https://t.co/9DI4KotyOp
Richard Conway RichardPAConway ( View Tweet)
Dr Elena Nikiphorou explaining how the Western diet can bring on and worsen inflammation joint disease symptoms. We should look to include more Omega 3 than Omega 6 in our diets #EULAR2022
PB https://t.co/nIKOSDPURU
ARD & RMD Open ARD_BMJ ( View Tweet)
A very comprehensive overview of progress in the understanding of #IIM pathogenetic mechanisms outlining the role of
👉 Type 1 INF pathway
👉 Vasculopathy
👉 NETs
👉 Mitochondrial Dysfunction
#EULAR2022
Dr. Lisa Rider https://t.co/BXbXlYTHYM
Ashima Makol MD AshimaMakol ( View Tweet)
van Dijk et al. MTP squeeze positivity is caused by both MTP synovitis (OR 3.2 (1.4–7.2) and intermetatarsal bursitis (OR 3.9 (1.7–8.8)). If + MTP squeeze - 10% synovitis, 15% IMB and 13% both @RheumNow #EULAR2022 OP0290 https://t.co/eVSU4i8gBK
Links:
Richard Conway RichardPAConway ( View Tweet)
Robert Landewe isn't lying down.
"I am chatting to my artificial intelligence doctor in the United States. I am asking him why I had a headache in the last talk"
He worries telehealth reverts to box checking, & we're not ready to drop thinking from medicine #EULAR2022 @RheumNow https://t.co/ApBS4T4Wpc
David Liew drdavidliew ( View Tweet)
CAR-T cell treatment of refractory systemic #lupus
Biological results
#SLE
#EULAR2022
>CR https://t.co/JK4lsWcn2c
ARD & RMD Open ARD_BMJ ( View Tweet)
Remission in PsA
❗️According to DAS28-CRP
*22% never achieve a state of remission
*< than half achieved at least stage of SR
❗️According to DAPSA28
*73% never achieve a state of remission
Are we that bad? Or do we need different measures? Or both?
@RheumNow
OP0262 #EULAR2022 https://t.co/6aeNW17VWg
Aurelie Najm AurelieRheumo ( View Tweet)
📈 Machine learning driven phenotyping in PsA
4 clusters of pts treated w/ Guselkumab identified 📊
1 cluster w/ higher BL disease burden associated w/ worst response
As fancy as it gets, not sure how to implement these in practice 🧐
@RheumNow #EULAR2022 OP0259 https://t.co/75X4ZqeEQJ
Aurelie Najm AurelieRheumo ( View Tweet)
@RichardPAConway @CatherineL_Hill @rheum_cat @RheumNow @KDAO2011 @uptoTate @AurelieRheumo Hello. @RheumNow reports @eular_org #EULAR2022 and teaches many. I learn as a tweeter. Way to go for all people tweeter this meeting. https://t.co/W3DuoVdfby
Janet Pope Janetbirdope ( View Tweet)
When Tweeps meet IRL #EULAR2022 #queensjubilee2022 @YelizPrior @DrMiniDey @chriswincup https://t.co/cnTFw2jjVd
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Sanchez-Bilboa at al. IV vs SC tocilizumab in 471 GCA patients. Equal efficacy. The authors report more adverse events with IV but actually this was purely due to longer follow up and per patient years it was the same. @RheumNow #EULAR2022 POS0272 https://t.co/2h7iIkMxjW
Richard Conway RichardPAConway ( View Tweet)
Just try and get into the great Tivoli Gardens after a day at #EULAR2022 https://t.co/qsGln5nH6S
Dr. John Cush RheumNow ( View Tweet)
Yusof et al @Yuz6Yusof COVID-19 in RTX treated patients. Significant efficacy of vaccination in both overall and severe COVID rates. Vaccination decreased risk HR 0.13 (0.03-0.51). Number comorbidities and low IgG increase risk @RheumNow #EULAR2022 OP0250 https://t.co/yD1tvs1UYt https://t.co/23XTtPb8fD
Links:
Richard Conway RichardPAConway ( View Tweet)
Pharmacodynamic effect of sequential #belimumab and #rituximab therapy in patients with systemic #lupus: BLISS-BELIEVE study
#EULAR2022
>CR https://t.co/AgBBuqYatW
ARD & RMD Open ARD_BMJ ( View Tweet)
#EULAR2022 virtual from my Copenhagen apartment this morning - you can’t watch three concurrent streams in person! @RheumNow https://t.co/Z74EOPn7kW
David Liew drdavidliew ( View Tweet)